search tools

Finally, a cure for swamp ass

Edit New York Post 04 Jul 2016
Crystal Hunter hit rock bottom at a bar one night a few years ago. The space was so crowded and hot, she tells The Post, that the cocktail napkins she was grabbing by the handful weren’t enough to mop up the sweat dripping from her butt ... The treatment, Hunter says, is “life-changing.” ... Norman M ... Neal Schultz ... Prescription pills, called anticholinergics, might help, but they aren’t very effective and can cause drowsiness, says Schultz ... ....

06-24-16 - Depression Decreases Adherence to COPD Maintenance Medications (ATS - American Thoracic Society)

Edit Public Technologies 24 Jun 2016
(Source. ATS - American Thoracic Society). Depression Decreases Adherence to COPD Maintenance Medications ... This included beneficiaries with two years of continuous Medicare Parts A, B and D coverage, and at least two prescription fills for inhaled corticosteroids, long-acting ß-agonists and long-acting anticholinergics. Adherence was based on the number of prescriptions filled ... Simoni-Wastila ... (noodl. 34257628) ....

Understanding how chemical changes in the brain affect Alzheimer's disease

Edit Science Daily 22 Jun 2016
A new study is helping to explain why the long-term use of common anticholinergic drugs used to treat conditions like allergies and overactive bladder lead to an increased risk of developing dementia later in life. The study used mouse models to show that long-term suppression of the neurotransmitter acetylcholine -- a target for anticholinergic drugs -- results in dementia-like changes in the brain ... ....

Understanding how chemical changes in the brain affect Alzheimer’s disease (The University of Western Ontario)

Edit Public Technologies 22 Jun 2016
(Source ... A new study from Western University is helping to explain why the long-term use of common anticholinergic drugs used to treat conditions like allergies and overactive bladder lead to an increased risk of developing dementia later in life. The findings show that long-term suppression of the neurotransmitter acetylcholine - a target for anticholinergic drugs - in the brain results in dementia-like changes ... MEDIA CONTACT ... 80387, c....

FLAME study evaluating efficacy of Ultibro® Breezhaler® to reduce chronic COPD exacerbations published in NEJM (Novartis Pharmaceuticals Canada Inc)

Edit Public Technologies 22 Jun 2016
(Source. Novartis Pharmaceuticals Canada Inc) Results published in the New England Journal of Medicine are anticipated to have important implications for the care of people living with COPD. Dorval, June 21 2016 - Novartis Pharmaceuticals Canada Inc ... The published FLAME results are anticipated to impact the future management and treatment of COPD patients ... About FLAME ... About COPD ... About Ultibro Breezhaler ... † a long-acting anticholinergic....

AstraZeneca to highlight the breadth of its respiratory medicines at American Thoracic Society 2016 International Conference 12 May 2016 (AstraZeneca Pharmaceuticals LP)

Edit Public Technologies 14 Jun 2016
BEVESPI AEROSPHERE is a combination of glycopyrrolate, an anticholinergic, and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA), indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema....

Alzheimer's Disease May Result From Past Brain Infections

Edit Mercola 09 Jun 2016
It's often stated as fact that Alzheimer's disease is the result of a buildup of beta-amyloid plaques in your brain. Such plaques may increase in your brain as you age, but tend to be far more abundant in people with Alzheimer's disease. Some people have a genetic mutation known to increase the production of beta-amyloid, but in most people the cause behind such buildup is unknown ... ✓ Avoid anticholinergics and statin drugs ... ....

Dermira Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Trials for DRM04 in Patients with Primary Axillary Hyperhidrosis (Dermira Inc)

Edit Public Technologies 01 Jun 2016
(NASDAQ.DERM), a biopharmaceutical company dedicated to identifying, developing and commercializing innovative, differentiated therapies to improve the lives of patients with dermatologic diseases, today announced topline results from its Phase 3 ATMOS-1 and ATMOS-2 pivotal trials for DRM04, a topical anticholinergic product candidate in development for patients with primary axillary hyperhidrosis (excessive underarm sweating)....

Help for uncontrollable eye twitches

Edit Herald Tribune 01 Jun 2016
DEAR DR. ROACH. I have blepharospasm (eye twitching, for those who have never heard of it). It’s terrible. I’m 58 and have had it for 10 years, but it has gotten worse as I’ve gotten older ... — B.S. ANSWER ... Oral medications usually are not effective, but there may be benefit from L-dopa-type drugs, from anticholinergic drugs (such as trihexyphenidyl) and from baclofen. All these have significant potential side effects ... DEAR DR. ROACH ... — G.D.T ... Dr....

Chronic pancreatitis requires enzyme replacement

Edit Herald Tribune 30 May 2016
DEAR DR. ROACH. I lost weight, and had terrible symptoms. My gastroenterologist gave me several tests but couldn't seem to make a diagnosis. Long story short, it was chronic pancreatitis, which my mom also has (we even had the same doctor) ... I think you might be referring to a recent study on anticholinergic drugs, which suggested that some older antihistamines, including diphenhydramine (Benadryl), might be associated with dementia risk ... ....

BEVESPI AEROSPHERE™ approved by the US FDA for patients with COPD 25 April 2016 (AstraZeneca Pharmaceuticals LP)

Edit Public Technologies 24 May 2016
BEVESPI AEROSPHERE is a combination of glycopyrrolate, an anticholinergic, and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA), indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema....

Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology Annual Meeting

Edit Stockhouse 24 May 2016
Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology Annual Meeting. — Company to Host Webcast Presentation and Conference Call on Wednesday, June 1 — ... Alkermes plc (NASDAQ ... – 2.00 p.m. MST ... MST ... MST ... Appropriate care is advised for patients who may exercise strenuously, may be exposed to extreme heat, receive concomitant medication with anticholinergic activity, or are subject to dehydration ... or....

Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology Annual Meeting (Alkermes plc)

Edit Public Technologies 24 May 2016
(Source. Alkermes plc) Alkermes to Present Data on ALKS 5461 at Upcoming American Society of Clinical Psychopharmacology Annual Meeting. - Company to Host Webcast Presentation and Conference Call on Wednesday, June 1 - ... - 2.00 p.m. MST ... MST ... MST ... Appropriate care is advised for patients who may exercise strenuously, may be exposed to extreme heat, receive concomitant medication with anticholinergic activity, or are subject to dehydration....
×
×
×
×